Cryo-Cell International Inc. CCEL

4.24 0.21 5.21% as of 25 Sep
Market cap
$32.5M
P/E
0.0×
Nov '25 Nov '24 Nov '23 Nov '22 Nov '21 Nov '20 Nov '19 Nov '18 Nov '17 Nov '16
P/E ratio
0.00 170.80 0.00 12.85 47.62 15.96 26.32 0.00 24.42 0.00
P/S ratio
1.02 2.17 1.42 1.22 3.49 1.82 1.85 1.87 2.24 1.49
P/FCF ratio
8.24 32.44 34.84 0.00 103.33 7.06 10.83 11.66 10.13 7.42
P/Operating CF
25.07 32.19 13.34 15.23 60.41 19.01 52.34 64.73 26.96 13.45
P/B ratio
0.00 0.00 0.00 0.00 24.07 0.00 0.00 0.00 0.00 0.00
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
1.24 2.43 1.70 1.52 3.30 1.68 1.80 1.97 2.19 1.65
EV/EBITDA
20.99 17.19 0.00 7.89 17.63 6.24 10.27 10.25 10.35 13.84
EV/Operating CF
7.17 12.94 5.98 5.38 12.01 6.18 9.10 10.79 9.71 7.65
EV/FCF
10.08 36.33 41.61 (6.86) 97.67 6.53 10.54 12.28 9.88 8.22
Quick Ratio
0.51 0.50 0.36 0.40 0.65 1.02 0.88 0.83 0.85 0.62
Current Ratio
0.59 0.58 0.45 0.49 0.75 1.13 1.00 0.96 0.91 0.69
Net Debt/EBITDA
3.83 1.84 (0.82) 1.56 (1.02) (0.50) 0.27 1.07 0.11 2.07
Debt/Assets
16.96% 18.29% 15.77% 16.73% 4.65% 13.46% 20.88% 30.53% 30.51% 50.26%
Debt/Equity
(0.56) (0.90) (0.87) (7.12) 0.67 (2.33) (1.29) (1.45) (0.58) (0.64)
Asset Turnover
0.50 0.51 0.50 0.48 0.54 0.70 0.75 0.88 1.17 1.18
Operating CF/Net income
(2.26) 14.95 (0.94) 3.09 3.80 2.34 2.75 (6.24) 2.47 (3.78)
Capex/Depreciation
(0.08) (3.46) (4.41) (8.38) (5.03) (0.62) (1.29) (1.51) (0.28) (0.15)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
15.27% (3.32%) 151.67% 208.38% 274.29% (75.37%) (28.89%) 7.98% (16.59%) 12.96%
ROA
(3.84%) 0.64% (15.10%) 4.41% 3.90% 8.14% 5.37% (2.58%) 10.66% (6.77%)
ROIC
0.00% 0.00% 0.00% 33.07% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(18.69%) 3.13% (99.33%) 74.26% (101.10%) 95.83% 126.94% (103.79%) (722.11%) 42.33%
Average Days of Receivables
79.16 83.41 76.58 72.72 66.38 74.10 69.95 73.29 73.70 63.96
Research and Development Expense of Revenue
1.19% 3.88% 3.74% 1.27% 0.17% 0.08% 0.09% 0.31% 0.16% 0.23%
Selling, General and Administrative Expense of Revenue
57.72% 57.91% 54.77% 51.36% 50.58% 45.89% 46.80% 53.50% 53.11% 63.66%
Intangible Assets out of Total Assets
0.05 0.04 0.05 0.26 0.30 0.08 0.07 0.08 0.01 0.01
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Graham Net Nets
(2.14) (0.94) (1.41) (1.54) (0.40) (0.54) (0.59) (0.67) (0.42) (0.75)
Graham Number
4.01 0.00 5.82 0.00 1.73 0.00 0.00 1.94 0.00 2.95
Earnings Yield
(7.79%) 0.59% (21.31%) 7.78% 2.10% 6.27% 3.80% (1.91%) 4.09% (4.79%)
Free Cash Flow Yield
12.13% 3.08% 2.87% (18.18%) 0.97% 14.17% 9.23% 8.58% 9.87% 13.47%
Revenue per Share
3.91 3.93 3.76 3.58 3.55 4.13 4.08 3.92 3.59 2.85
Operating CF per Share
0.68 0.74 1.07 1.01 0.97 1.12 0.81 0.71 0.81 0.61
Capex per Share
(0.01) (0.44) (0.92) (1.81) (0.85) (0.06) (0.08) (0.09) (0.01) (0.04)
Free Cash Flow per Share
0.66 0.30 0.15 (0.79) 0.12 1.06 0.72 0.63 0.80 0.57
Cash per Share
0.41 0.43 0.12 0.20 1.02 1.39 0.96 0.93 0.95 0.51
Shareholders Equity per Share
(2.31) (1.63) (1.32) (0.18) 0.51 (0.35) (0.89) (1.19) (1.77) (1.90)
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
(2.31) (1.63) (1.32) (0.18) 0.51 (0.35) (0.89) (1.19) (1.77) (1.90)
Free Cash Flow
5.36 2.41 1.28 (6.73) 0.97 8.02 5.63 4.69 5.62 4.65
Working Capital
(8.03) (9.04) (11.41) (9.87) (5.29) 2.14 (0.04) (0.67) (1.20) (4.10)
Capital Expenditures
(0.12) (3.60) (7.64) (15.30) (6.95) (0.45) (0.66) (0.65) (0.10) (0.34)
Net Current Asset Value
(68.58) (65.34) (62.80) (56.80) (40.70) (30.31) (34.45) (36.54) (23.68) (25.94)
EV/EBIT
81.46 22.35 0.00 11.46 23.70 6.83 11.31 11.09 11.09 88.04
Capex to Sales
0.00 0.11 0.24 0.50 0.24 0.01 0.02 0.02 0.00 0.01
Net Profit Margin
(7.70%) 1.26% (30.38%) 9.14% 7.21% 11.64% 7.20% (2.93%) 9.12% (5.71%)
Price to Operating Income
66.58 19.95 0.00 9.19 25.07 7.38 11.62 10.53 11.37 79.52
Other line items
Depreciation/Fixed assets
0.07 0.05 0.08 0.13 0.43 0.44 0.28 0.29 0.40 2.37
Cash ROIC
321.41% (752.73%) 3,032.92% (45.53%) 30.60% 48.75% 47.08% 35.06% 320.08% (272.61%)
Accounts Receivable Turnover
4.46 4.61 4.97 5.37 4.99 5.02 5.32 5.32 5.53 6.50
Accounts Payable Turnover
3.10 3.14 3.51 5.68 7.35 8.30 7.63 5.35 3.94 4.10
Inventory Turnover
13.83 11.14 10.36 9.92 9.73 9.60 8.56 10.84 19.90 13.80
Average Days of Payables
142.05 86.44 138.10 66.64 60.49 36.18 49.79 53.93 104.68 93.89
Days of Inventory on Hand
20.23 30.20 33.45 35.34 37.40 35.05 39.44 53.88 17.08 22.82
Average Receivables
7.08 6.94 6.31 5.65 5.79 6.21 5.98 5.50 4.59 3.56
Average Payables
2.38 2.53 2.39 1.55 1.22 1.16 1.32 1.60 1.71 1.41
Average Inventory
0.53 0.71 0.81 0.89 0.92 1.01 1.17 0.79 0.34 0.42
Average Assets
63.20 62.95 63.05 62.78 53.43 44.54 42.64 33.15 21.72 19.52
Average Common Equity
(15.91) (12.12) (6.28) 1.33 0.76 (4.81) (7.93) (10.71) (13.96) (10.19)

Fold the line items

Columns are period end dates